THE SCHEDULE 13G

Company

Aclaris Therapeutics, Inc.

Filed

January 24, 2022

Accession Number

0000921895-22-000227

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →